Nextech Invest Ltd. reported 18 holdings worth US$2.23B as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Nextech Invest Ltd. reported 18 holdings worth US$2.23B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Parabilis Medicines, Inc. and Relay Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 18
- Value as reported
- US$2.23B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Revolution Medicines, Inc. | 7.6M | US$1.56B | 69.9% |
| Parabilis Medicines, Inc. | 4.66M | US$151M | 6.7% |
| Relay Therapeutics, Inc. | 6.78M | US$122M | 5.5% |
| ORIC Pharmaceuticals, Inc. | 7.16M | US$96.5M | 4.3% |
| Tyra Biosciences, Inc. | 3.45M | US$75.4M | 3.4% |
| Alumis Inc. | 4.55M | US$33.6M | 1.5% |
| Attovia Therapeutics, Inc. | 1.84M | US$31.5M | 1.4% |
| Kymera Therapeutics, Inc. | 279K | US$31.2M | 1.4% |
| Electra Therapeutics, Inc. | 2.64M | US$29.7M | 1.3% |
| Zymeworks Inc. | 1.11M | US$29.5M | 1.3% |
| Silence Therapeutics PLC | 1.69M | US$18.5M | 0.83% |
| CytomX Therapeutics, Inc. | 4.45M | US$12.1M | 0.54% |
| Avalo Therapeutics, Inc. | 766K | US$11.7M | 0.53% |
| Monte Rosa Therapeutics, Inc. | 761K | US$9.08M | 0.41% |
| Braveheart Bio, Inc. | 417K | US$8.42M | 0.38% |
| Corvus Pharmaceuticals, Inc. | 450K | US$5.18M | 0.23% |
| Context Therapeutics Inc. | 7.42M | US$2.23M | 0.10% |
| Arvinas, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC